Inactive Instrument
Genex Pharmaceutical, Inc. Stock Other OTC
Stocks
GENX
US37227T1051
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 268K 234K 216K 200K 376K 25.71M 383K 2.58M 1.01M 12.59M 1.01M 983K 43.35M | P/E 2006 |
3.75x | P/E 2007 | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 413K 361K 333K 308K 580K 39.63M 590K 3.97M 1.56M 19.4M 1.55M 1.52M 66.81M | EV / Sales 2006 |
0.95x | EV / Sales 2007 | 1.6x |
| Free-Float |
99.62% | Yield 2006 * |
-
| Yield 2007 | - |
| 1 day | -4.55% |
| Manager | Title | Age | Since |
|---|---|---|---|
Fuzhi Song
CEO | Chief Executive Officer | 72 | - |
Shuli Zhang
DFI | Director of Finance/CFO | 72 | 2010-02-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Fuzhi Song
CHM | Chairman | 72 | 2010-02-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.55% | -39.83% | - | - | 1.78K | |
| +1.70% | -3.17% | -18.97% | +5.99% | 119B | |
| +3.32% | +2.22% | +4.68% | -2.62% | 12.58B | |
| +2.61% | +2.21% | +59.11% | +99.82% | 8.95B | |
| +9.11% | +8.09% | -46.36% | -70.81% | 3.85B | |
| +3.08% | +9.29% | +27.49% | +54.14% | 2.82B | |
| +3.86% | -4.05% | -14.95% | -27.03% | 1.67B | |
| +1.54% | +3.06% | -1.45% | -19.99% | 1.64B | |
| +5.25% | +9.90% | -15.95% | -60.04% | 1.42B | |
| Average | +2.89% | +1.35% | -0.80% | -2.57% | 19.02B | |
| Weighted average by Cap. | +2.19% | -4.17% | -11.99% | +8.49% |
| 2006 | 2007 | |
|---|---|---|
| Net sales | 2.44M 2.13M 1.97M 1.82M 3.43M 234M 3.49M 23.49M 9.22M 115M 9.16M 8.96M 395M | 3.24M 2.83M 2.62M 2.42M 4.55M 311M 4.63M 31.19M 12.24M 152M 12.16M 11.89M 524M |
| Net income | 619K 541K 500K 462K 870K 59.45M 886K 5.96M 2.34M 29.11M 2.32M 2.27M 100M | 343K 299K 277K 256K 481K 32.9M 490K 3.3M 1.29M 16.11M 1.29M 1.26M 55.48M |
| Net Debt | -0.19 -0.17 -0.16 -0.14 -0.27 -18.46 -0.28 -1.85 -0.73 -9.04 -0.72 -0.71 -31.13 | 0.14 0.13 0.12 0.11 0.2 13.91 0.21 1.4 0.55 6.81 0.54 0.53 23.46 |
Employees
-
Choose MarketScreener 
